Skip to content

Berberine Chloride Stabilizes Coronary Atherosclerotic Plaques in Clinical Research

Berberine Chloride Stabilizes Coronary Atherosclerotic Plaques in Clinical Research

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003691
Enrollment
Unknown
Registered
2013-07-22
Start date
2013-10-08
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease

Interventions

Treatment group:Rosuvastatin+Berberine
Control group:Rosuvastatin

Sponsors

Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 90 Years

Inclusion criteria

Inclusion criteria: By coronary angiography for the diagnosis of coronary heart disease (the main branch stenosis = 50% and <70%) of patients with stable angina

Exclusion criteria

Exclusion criteria: 1. Exclude the cause of elevated CRP diseases (such as the recent infection, trauma, rheumatic activity, etc.)and significant liver and kidney dysfunction or recent hepatitis persons; 2. Concomitant diseases, such as cancer, thyroid disease, tuberculosis or taking hormones; 3. The combined effect on hemodynamics in patients with valvular heart disease; 4. Drug side effects or unacceptable IVUS follow-up; 5. Associated with mental illness, such as depression, mania, and not long-term cooperation mental disorders; 6. Alcoholism or drug addicts.

Design outcomes

Primary

MeasureTime frame
Triglycerides;Cholesterol;High-density lipoprotein;Low-density lipoprotein;Serum creatinine;hsCRP;MMP-9;ICAM-1;VCAM-1;NF-kB;p38;AMP;ERK;PPAR;

Countries

China

Contacts

Public ContactMeng Shu

Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

msdoctor@sohu.com+86 13916005250

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026